×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Download App

Indian patent grants US Pharmaceutical firm monopoly to control medicine products

 

(Photo: Courtesy)

HIV, tuberculosis, and malaria patients in Kenya are among millions globally at risk following a decision that could limit access to cheap generic drugs, including vaccines from India.

Get Full Access for Ksh299/Week.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in